ExploreWatchlistsPricing
  1. JP-listed companies
  2. KNC Laboratories Co., Ltd.
  3. Financials
  4. EBITDA margin (%)

KNC Laboratories Co., Ltd. (6568)

Market cap
¥10B
P/E ratio
16.5x
Develops and manufactures specialized organic chemicals for pharmaceutical, electronics, and biotech companies to accelerate their product development.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 202520.2-38.47%
Mar 31, 202432.8-8.17%
Mar 31, 202335.7+31.37%
Mar 31, 202227.2+4.11%
Mar 31, 202126.1+20.37%
Mar 31, 202021.7-31.58%
Mar 31, 201931.7-0.09%
Mar 31, 201831.7-2.01%
Mar 31, 201732.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat